Identification of cancer drug sensitivity biomarkers

Ehsan Ullah, RaghvenPhDa Mall, Halima Bensmail, Reda Rawi, Saila Shama, Nooral Al Muftah, Ian Richard Thmpson

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Anti-cancer therapies have different responses to different patients. There is a need to identify biomarkers for effectiveness of drugs beside the biomarkers for the diseases like cancer to advance the field personalized medicine. We have used a panel of cancer cell lines from Genomics of Drug Sensitivity in Cancer (GDSC) to capture the sensitivity of drugs. By combining the genetic information such as mutations, copy number variations and gene expression levels from Catalogue of Somatic Mutations in Cancer (COSMIC) and The Cancer Genome ATLAS (TCGA) for the afore mentioned cell lines, we are able to identify genomic features associated with the sensitivity of the drugs.

Original languageEnglish
Title of host publicationProceedings - 2017 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2017
PublisherInstitute of Electrical and Electronics Engineers Inc.
Pages2322-2324
Number of pages3
Volume2017-January
ISBN (Electronic)9781509030491
DOIs
Publication statusPublished - 15 Dec 2017
Event2017 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2017 - Kansas City, United States
Duration: 13 Nov 201716 Nov 2017

Other

Other2017 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2017
CountryUnited States
CityKansas City
Period13/11/1716/11/17

Fingerprint

Biomarkers
Cells
Gene expression
Pharmaceutical Preparations
Medicine
Neoplasms
Genes
Cell Line
Precision Medicine
Mutation
Genomics
Genome
Gene Expression

Keywords

  • association analysis
  • biomarkers
  • cancer
  • drug sensitivity
  • genomics
  • statistical analysis

ASJC Scopus subject areas

  • Biomedical Engineering
  • Health Informatics

Cite this

Ullah, E., Mall, R., Bensmail, H., Rawi, R., Shama, S., Muftah, N. A., & Thmpson, I. R. (2017). Identification of cancer drug sensitivity biomarkers. In Proceedings - 2017 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2017 (Vol. 2017-January, pp. 2322-2324). Institute of Electrical and Electronics Engineers Inc.. https://doi.org/10.1109/BIBM.2017.8218043

Identification of cancer drug sensitivity biomarkers. / Ullah, Ehsan; Mall, RaghvenPhDa; Bensmail, Halima; Rawi, Reda; Shama, Saila; Muftah, Nooral Al; Thmpson, Ian Richard.

Proceedings - 2017 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2017. Vol. 2017-January Institute of Electrical and Electronics Engineers Inc., 2017. p. 2322-2324.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Ullah, E, Mall, R, Bensmail, H, Rawi, R, Shama, S, Muftah, NA & Thmpson, IR 2017, Identification of cancer drug sensitivity biomarkers. in Proceedings - 2017 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2017. vol. 2017-January, Institute of Electrical and Electronics Engineers Inc., pp. 2322-2324, 2017 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2017, Kansas City, United States, 13/11/17. https://doi.org/10.1109/BIBM.2017.8218043
Ullah E, Mall R, Bensmail H, Rawi R, Shama S, Muftah NA et al. Identification of cancer drug sensitivity biomarkers. In Proceedings - 2017 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2017. Vol. 2017-January. Institute of Electrical and Electronics Engineers Inc. 2017. p. 2322-2324 https://doi.org/10.1109/BIBM.2017.8218043
Ullah, Ehsan ; Mall, RaghvenPhDa ; Bensmail, Halima ; Rawi, Reda ; Shama, Saila ; Muftah, Nooral Al ; Thmpson, Ian Richard. / Identification of cancer drug sensitivity biomarkers. Proceedings - 2017 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2017. Vol. 2017-January Institute of Electrical and Electronics Engineers Inc., 2017. pp. 2322-2324
@inproceedings{b63afdd4de89470ba857b6a83f8e2d73,
title = "Identification of cancer drug sensitivity biomarkers",
abstract = "Anti-cancer therapies have different responses to different patients. There is a need to identify biomarkers for effectiveness of drugs beside the biomarkers for the diseases like cancer to advance the field personalized medicine. We have used a panel of cancer cell lines from Genomics of Drug Sensitivity in Cancer (GDSC) to capture the sensitivity of drugs. By combining the genetic information such as mutations, copy number variations and gene expression levels from Catalogue of Somatic Mutations in Cancer (COSMIC) and The Cancer Genome ATLAS (TCGA) for the afore mentioned cell lines, we are able to identify genomic features associated with the sensitivity of the drugs.",
keywords = "association analysis, biomarkers, cancer, drug sensitivity, genomics, statistical analysis",
author = "Ehsan Ullah and RaghvenPhDa Mall and Halima Bensmail and Reda Rawi and Saila Shama and Muftah, {Nooral Al} and Thmpson, {Ian Richard}",
year = "2017",
month = "12",
day = "15",
doi = "10.1109/BIBM.2017.8218043",
language = "English",
volume = "2017-January",
pages = "2322--2324",
booktitle = "Proceedings - 2017 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2017",
publisher = "Institute of Electrical and Electronics Engineers Inc.",

}

TY - GEN

T1 - Identification of cancer drug sensitivity biomarkers

AU - Ullah, Ehsan

AU - Mall, RaghvenPhDa

AU - Bensmail, Halima

AU - Rawi, Reda

AU - Shama, Saila

AU - Muftah, Nooral Al

AU - Thmpson, Ian Richard

PY - 2017/12/15

Y1 - 2017/12/15

N2 - Anti-cancer therapies have different responses to different patients. There is a need to identify biomarkers for effectiveness of drugs beside the biomarkers for the diseases like cancer to advance the field personalized medicine. We have used a panel of cancer cell lines from Genomics of Drug Sensitivity in Cancer (GDSC) to capture the sensitivity of drugs. By combining the genetic information such as mutations, copy number variations and gene expression levels from Catalogue of Somatic Mutations in Cancer (COSMIC) and The Cancer Genome ATLAS (TCGA) for the afore mentioned cell lines, we are able to identify genomic features associated with the sensitivity of the drugs.

AB - Anti-cancer therapies have different responses to different patients. There is a need to identify biomarkers for effectiveness of drugs beside the biomarkers for the diseases like cancer to advance the field personalized medicine. We have used a panel of cancer cell lines from Genomics of Drug Sensitivity in Cancer (GDSC) to capture the sensitivity of drugs. By combining the genetic information such as mutations, copy number variations and gene expression levels from Catalogue of Somatic Mutations in Cancer (COSMIC) and The Cancer Genome ATLAS (TCGA) for the afore mentioned cell lines, we are able to identify genomic features associated with the sensitivity of the drugs.

KW - association analysis

KW - biomarkers

KW - cancer

KW - drug sensitivity

KW - genomics

KW - statistical analysis

UR - http://www.scopus.com/inward/record.url?scp=85046294354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046294354&partnerID=8YFLogxK

U2 - 10.1109/BIBM.2017.8218043

DO - 10.1109/BIBM.2017.8218043

M3 - Conference contribution

AN - SCOPUS:85046294354

VL - 2017-January

SP - 2322

EP - 2324

BT - Proceedings - 2017 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2017

PB - Institute of Electrical and Electronics Engineers Inc.

ER -